Kalbe Farma Tbk PT ADR (PTKFY PINK) stock market data APIs
$18.4808
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
Kalbe Farma Tbk PT ADR Financial Data Overview
Price chart is built with
Anychart
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is based in Jakarta, Indonesia.
Prev. Close
18.4808
Open
18.4808
High
18.4808
Low
18.4808
52 wk Range
12-23.724
Market Cap
4 603 M
P/E Ratio
20.5
Shares Outstanding
234 M
Revenue
33 110 115 M
EPS
0.287
Dividends (Yield)
0.0255
Beta
0.061
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kalbe Farma Tbk PT ADR data using free add-ons & libraries
Get Kalbe Farma Tbk PT ADR Fundamental Data
Kalbe Farma Tbk PT ADR Fundamental data includes:
- Net Revenue: 33 110 115 M
- EBITDA: 4 989 280 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kalbe Farma Tbk PT ADR News
New
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting erythropoietin (EPO) for the treatment of Chronic Kidney disease Induced anemia Labe...
SE Asia Stocks-Most gain on new stimulus in Japan; Philippines slips
* Singapore closes at highest since April 20 * Extended lockdown in Singapore to help Singtel - analyst * Philippines cenbank warns of annual GDP contraction By Nikhil Subba April 27 (Reuters) - Most ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
